Riskpilot← Back to searchSign inGet full accessMedularity Systems AB
ABActiveOrg 5590788393Bergshauptmansgatan 15General medical practice activities · NACE 8621Est. 20160 employees
Revenue 2025
SEK 567K
-13% vs 2024
EBITDA margin
91.4%
-10% vs 2024
Equity ratio
98.8%
Financial strength
Net profit 2025
SEK 414K
-10% vs 2024
| Revenue | SEK 567K | -13% |
| EBITDA | SEK 518K | -10% |
| Net profit | SEK 414K | -10% |
| Total assets | SEK 4,5M | +7% |
| Equity | SEK 4,5M | +8% |
| Employees | 0 | — |
Legal name
Medularity Systems AB
Org number
5590788393
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 oktober 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska utveckla och sälja mjukvara (software) samt därmed förenlig verksamhet. Aktiebolag ska dessutom bedriva medicinskt konsultverksamhet samt därmed förenlig verksamhet.
Address
Bergshauptmansgatan 15
Email
pargac.julius@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 158 | 1 307 | 863 | 648 | 567 |
| Staff expenses | — | — | −1 | −0 | −0 |
| EBITDA | 2 125 | 1 281 | 815 | 574 | 518 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 2 125 | 1 281 | 815 | 574 | 518 |
| Net financials | — | −1 | 5 | 4 | 3 |
| Profit before tax | 2 125 | 1 280 | 821 | 578 | 521 |
| Tax | −438 | −264 | −168 | −119 | −107 |
| Net profit | 1 687 | 1 016 | 653 | 459 | 414 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 269 | 3 487 | 4 029 | 4 236 | 4 534 |
| Equity | 4 980 | 3 236 | 3 799 | 4 168 | 4 482 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 289 | 252 | 230 | 68 | 52 |
| Total debt | 289 | 252 | 230 | 68 | 52 |
EBITDA margin
91.4%
This company
15.8%
Market median
+478% vs market
20212025
Equity ratio
98.8%
This company
38.2%
Market median
+159% vs market
20212025
Return on equity
9.2%
This company
18.4%
Market median
-50% vs market
20212025
Net profit margin
73.1%
This company
8.1%
Market median
+802% vs market
20212025
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medularity Systems AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Johann Julius Pargác | Board of Directors | 0 companies |
| Gustav Mats Rosenqvist | Deputy Board Member | 0 companies |